FI119571B - Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä - Google Patents

Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä Download PDF

Info

Publication number
FI119571B
FI119571B FI20021598A FI20021598A FI119571B FI 119571 B FI119571 B FI 119571B FI 20021598 A FI20021598 A FI 20021598A FI 20021598 A FI20021598 A FI 20021598A FI 119571 B FI119571 B FI 119571B
Authority
FI
Finland
Prior art keywords
value
gastrin
pepsinogen
individual
marker
Prior art date
Application number
FI20021598A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20021598A0 (fi
FI20021598A (fi
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Publication of FI20021598A0 publication Critical patent/FI20021598A0/fi
Priority to FI20021598A priority Critical patent/FI119571B/fi
Priority to EP03793839A priority patent/EP1552311B1/en
Priority to KR1020057003839A priority patent/KR101108282B1/ko
Priority to DE60324698T priority patent/DE60324698D1/de
Priority to CN03821224.2A priority patent/CN1682115A/zh
Priority to PCT/FI2003/000653 priority patent/WO2004023148A1/en
Priority to AU2003260530A priority patent/AU2003260530A1/en
Priority to JP2004533540A priority patent/JP4261481B2/ja
Priority to AT03793839T priority patent/ATE414282T1/de
Priority to EA200500449A priority patent/EA007003B1/ru
Publication of FI20021598A publication Critical patent/FI20021598A/fi
Application granted granted Critical
Publication of FI119571B publication Critical patent/FI119571B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20021598A 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä FI119571B (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20021598A FI119571B (fi) 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
CN03821224.2A CN1682115A (zh) 2002-09-06 2003-09-05 在个体中检测酸相关性疾病危险性的方法
KR1020057003839A KR101108282B1 (ko) 2002-09-06 2003-09-05 개체의 산 관련 질병의 위험도를 검사하는 방법
DE60324698T DE60324698D1 (de) 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum
EP03793839A EP1552311B1 (en) 2002-09-06 2003-09-05 Method for detecting a risk of acid related disease in an individual
PCT/FI2003/000653 WO2004023148A1 (en) 2002-09-06 2003-09-05 Method for detecting a risk of acid related disease in an individual
AU2003260530A AU2003260530A1 (en) 2002-09-06 2003-09-05 Method for detecting a risk of acid related disease in an individual
JP2004533540A JP4261481B2 (ja) 2002-09-06 2003-09-05 個体の酸関連疾患の危険性を検出する方法
AT03793839T ATE414282T1 (de) 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum
EA200500449A EA007003B1 (ru) 2002-09-06 2003-09-05 Способ выявления риска развития у субъекта заболевания, связанного с кислотой

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20021598 2002-09-06
FI20021598A FI119571B (fi) 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä

Publications (3)

Publication Number Publication Date
FI20021598A0 FI20021598A0 (fi) 2002-09-06
FI20021598A FI20021598A (fi) 2004-03-07
FI119571B true FI119571B (fi) 2008-12-31

Family

ID=8564544

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021598A FI119571B (fi) 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä

Country Status (10)

Country Link
EP (1) EP1552311B1 (zh)
JP (1) JP4261481B2 (zh)
KR (1) KR101108282B1 (zh)
CN (1) CN1682115A (zh)
AT (1) ATE414282T1 (zh)
AU (1) AU2003260530A1 (zh)
DE (1) DE60324698D1 (zh)
EA (1) EA007003B1 (zh)
FI (1) FI119571B (zh)
WO (1) WO2004023148A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076499A2 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
WO2004088326A2 (en) 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
WO2006032980A1 (en) 2004-09-22 2006-03-30 Receptor Biologix, Inc. Monoclonal antibolies to progastrin
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
EP2585957A4 (en) 2010-06-24 2014-12-24 Valtion Teknillinen STATE DEDUCTION IN A HETEROGENEOUS SYSTEM
CN113514647A (zh) * 2014-06-13 2021-10-19 拜奥希特公司 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途
CA3066756A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
KR102637908B1 (ko) * 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi

Also Published As

Publication number Publication date
CN1682115A (zh) 2005-10-12
ATE414282T1 (de) 2008-11-15
EP1552311A1 (en) 2005-07-13
WO2004023148A1 (en) 2004-03-18
EA200500449A1 (ru) 2005-08-25
DE60324698D1 (de) 2008-12-24
FI20021598A0 (fi) 2002-09-06
EA007003B1 (ru) 2006-06-30
JP4261481B2 (ja) 2009-04-30
FI20021598A (fi) 2004-03-07
AU2003260530A1 (en) 2004-03-29
KR20050057220A (ko) 2005-06-16
JP2005538348A (ja) 2005-12-15
KR101108282B1 (ko) 2012-01-31
EP1552311B1 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
Ayling et al. Fecal calprotectin
Inoue et al. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies
Montalto et al. Role of fecal calprotectin in gastrointestinal disorders
RU2262706C2 (ru) Способ для диагностики атрофических гастритов
Skrebinska et al. Diagnosis of Helicobacter pylori infection
Iijima et al. Cutoff serum pepsinogen values for predicting gastric acid secretion status
Kayazawa et al. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins
RU2225615C2 (ru) Способ дифференциации между наличием риска образования язвы желудка и язвы двенадцатиперстной кишки
WO2015182580A1 (ja) 大腸がんの転移検出方法
FI119571B (fi) Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
ES2389022T3 (es) Mioglobina como predictor precoz del infarto de miocardio
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
JP6865280B2 (ja) ヘリコバクター・ピロリ胃炎および萎縮性胃炎と関連リスクの改善された検出方法
CN106501532A (zh) 一种用于检测胃泌素17的试剂盒
Ebik et al. What is the incidence of celiac disease in patients with microscopic colitis? Why are these two diseases related?
Miftahussurur et al. Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
JP7201966B2 (ja) 自己免疫性胃炎の検出方法
US20190324018A1 (en) Saliva reagent strip for detecting concentration of pepsin or pepsinogen
RU2580309C1 (ru) Способ иммунодиагностики рака желудка
RIMAC Procalcitonin-potential, limitations and availability
Esteve i Comas et al. Case-finding in primary care for coeliac disease: Accuracy and cost-effectiveness of a rapid point-of-care test
Kurbanovna PREDICTING THE RISK OF ATROPHIC TRANSFORMATION IN CHRONIC GASTRITIS USING SERUM PEPSINOGEN
FI20215799A1 (en) Combined GastroPanel in one microplate
JPWO2020158811A5 (zh)

Legal Events

Date Code Title Description
MA Patent expired